168 related articles for article (PubMed ID: 30283326)
1. A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma.
Hidaka T; Chuman H; Nao-I N
Case Rep Ophthalmol; 2018; 9(2):401-404. PubMed ID: 30283326
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma.
Vale S; Montalvo L; Baez E; Oliver AL
Am J Ophthalmol Case Rep; 2018 Mar; 9():45-47. PubMed ID: 29468218
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.
Sothornwit N
J Med Assoc Thai; 2008; 91 Suppl 1():S162-5. PubMed ID: 18672609
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma.
Ghanem AA; El-Kannishy AM; El-Wehidy AS; El-Agamy AF
Middle East Afr J Ophthalmol; 2009 Apr; 16(2):75-9. PubMed ID: 20142965
[TBL] [Abstract][Full Text] [Related]
5. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma.
Marey HM; Ellakwa AF
Clin Ophthalmol; 2011; 5():841-5. PubMed ID: 21750619
[TBL] [Abstract][Full Text] [Related]
7. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
[TBL] [Abstract][Full Text] [Related]
8. Role of intravitreal bevacizumab in neovascular glaucoma.
Gheith ME; Siam GA; de Barros DS; Garg SJ; Moster MR
J Ocul Pharmacol Ther; 2007 Oct; 23(5):487-91. PubMed ID: 17900231
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS.
Seidman CJ; Finger PT; Silverman JS; Oratz R
Retin Cases Brief Rep; 2017 Winter; 11(1):47-50. PubMed ID: 26862924
[TBL] [Abstract][Full Text] [Related]
11. Use of Intravitreal Bevacizumab for the Treatment of Secondary Glaucoma Caused by Metastatic Iris Tumor.
Aydin R; Tezel TH
J Glaucoma; 2018 Jun; 27(6):e113-e116. PubMed ID: 29613980
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab (Avastin) for the management of anterior chamber neovascularization and neovascular glaucoma.
Brouzas D; Charakidas A; Moschos M; Koutsandrea C; Apostolopoulos M; Baltatzis S
Clin Ophthalmol; 2009; 3():685-8. PubMed ID: 20054417
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.
Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H
J Ocul Pharmacol Ther; 2009 Jun; 25(3):259-64. PubMed ID: 19348598
[TBL] [Abstract][Full Text] [Related]
15. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
Ouhadj O; Chergui I; Mendil L; Nouri MT
J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
17. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
Duch S; Buchacra O; Milla E; Andreu D; Tellez J
J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
[TBL] [Abstract][Full Text] [Related]
19. A case of cholesterosis bulbi with secondary glaucoma treated by vitrectomy and intravitreal bevacizumab.
Park J; Lee H; Kim YK; Chae JD; Lee HJ
Korean J Ophthalmol; 2011 Oct; 25(5):362-5. PubMed ID: 21976948
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
Chen CH; Lai IC; Wu PC; Chen YJ; Chen YH; Lee JJ; Liu YC; Kuo HK
J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
